Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:e161
Published online before print September 24, 2007, doi: 10.1161/HYPERTENSIONAHA.107.097808
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/5/e161    most recent
HYPERTENSIONAHA.107.097808v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blacher, J.
Right arrow Articles by Rudnichi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blacher, J.
Right arrow Articles by Rudnichi, A.
Related Collections
Right arrow Risk Factors
Right arrow Other hypertension
Right arrow Clinical Studies

(Hypertension. 2007;50:e161.)
© 2007 American Heart Association, Inc.


Letters to the Editor

Brachial Pulse Pressure and Cardiovascular Risk

Jacques Blacher; Michel E. Safar; Claire Vesin; Annie Rudnichi

Paris Descartes University, Diagnosis Center, Hôtel-Dieu Hospital, AP-HP, Paris, France

To the Editor:

The study by Mosley et al1 shows in a large population that, in the predictive value of cardiovascular (CV) risk, pulse pressure (PP) is less effective than systolic (SBP) or diastolic blood pressure (BP). This finding supports the usual approach of major current guidelines but also raises major questions related to SBP and PP (here measured exclusively at the site of the brachial artery).

First, the classification into SBP or PP reflects, in fact, a particular approach in the clinical management of CV risk. The former depends largely on the (arbitrary) definition of hypertension, whereas the latter involves risk in the totality of a given population. Indeed, PP is, by definition, a risk factor observed both in normotensive and hypertensive subjects. Furthermore, the understanding of PP requires us to admit that BP propagates at a given velocity (pulse wave velocity) along the totality of the arterial tree, involves the presence of wave reflections, and is characterized by the presence of aortic-brachial SBP and PP amplification. To our knowledge, nowadays, no guideline in the literature indicates such very simple and basic definitions of CV physiology.

Second, all of the statistical evaluations on SBP and PP have in common the same difficulty, ie, the problem of colinearity of the different components of BP measurements. This problem is poorly discussed in the literature, but the "principal component analysis" is one of the most available statistical methodologies to perform in such conditions. This was done only in a single article of the literature.2

Third, several groups have extensively shown that SBP and PP increase markedly with age, mostly for PP. The Framingham Study has indicated that the predictive value of PP is observed only at >60 years of age.3 When hypertension began to be considered as a "disease" to treat, most of the cohorts of the literature were studied on the basis of young hypertensive populations, as in the Chicago cohort. In such conditions, there is little chance that PP could be attributed exclusively to increased arterial stiffness. Thus, it is important nowadays to indicate in the various cohorts the number of subjects by age class and to obtain a long-term follow-up of subjects >70 years of age.

Finally, the population of this article1 has 2 major particularities that might explain some results: the mean age at entry in the cohort was 39 years, and at this age, it is well accepted that diastolic BP is the BP component that is more closely related to CV risk; and the follow-up is particularly long (33 years), so that a regression dilution bias should limit the ability of comparing the various BP components for CV risk prediction.


*    Acknowledgments
 
Disclosures

None.


*    References
up arrowTop
*References
 
1. Mosley WJ II, Greenland P, Garside DB, Lloyd-Jones DM. Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension. 2007; 49: 1256–1264.[Abstract/Free Full Text]

2. Darné B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady comment of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989; 13: 392–400.[Abstract/Free Full Text]

3. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999; 100: 354–360.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
HypertensionHome page
W. J. Mosley II, P. Greenland, D. B. Garside, and D. M. Lloyd-Jones
Response to Brachial Pulse Pressure and Cardiovascular Risk
Hypertension, November 1, 2007; 50(5): e162 - e162.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/5/e161    most recent
HYPERTENSIONAHA.107.097808v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blacher, J.
Right arrow Articles by Rudnichi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blacher, J.
Right arrow Articles by Rudnichi, A.
Related Collections
Right arrow Risk Factors
Right arrow Other hypertension
Right arrow Clinical Studies